We are pleased to share a selection of papers published in 2024 on the topic of advances in lung cancer: AI applications, biomarkers, and emerging therapeutic strategies, in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.

1. “Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review”
by Filippo Lococo, Galal Ghaly, Marco Chiappetta, Sara Flamini, Jessica Evangelista, Emilio Bria, Alessio Stefani, Emanuele Vita, Antonella Martino, Luca Boldrini et al.
Cancers 2024, 16(10), 1832; https://doi.org/10.3390/cancers16101832
Available online: https://www.mdpi.com/2072-6694/16/10/1832

2. “The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma”
by Yeonhee Park, Dahye Lee, Jeong Eun Lee, Hee Sun Park, Sung Soo Jung, Dongil Park, Da Hyun Kang, Song-I Lee, Seong-Dae Woo and Chaeuk Chung
Cancers 2024, 16(3), 598; https://doi.org/10.3390/cancers16030598
Available online: https://www.mdpi.com/2072-6694/16/3/598

3. “ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer”
by Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, Marcelo Corassa, Philip C. Mack, Jhanelle E. Gray and Bruna Pellini
Cancers 2024, 16(5), 940; https://doi.org/10.3390/cancers16050940
Available online: https://www.mdpi.com/2072-6694/16/5/940

4. “The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer”
by Yunxia Ma, Miljana Nenkov, Alexander Berndt, Mohamed Abubrig, Martin Schmidt, Tim Sandhaus, Otmar Huber, Joachim H. Clement, Susanne M. Lang, Yuan Chen et al.
Cancers 2024, 16(6), 1170; https://doi.org/10.3390/cancers16061170
Available online: https://www.mdpi.com/2072-6694/16/6/1170

5. “Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies”
by Pernelle Lavaud, Martina Bortolot, Lodovica Zullo, David O’Reilly, Jarushka Naidoo, Giannis Mountzios, Olaf Mercier, Lizza E. L. Hendriks and Jordi Remon
Cancers 2024, 16(16), 2779; https://doi.org/10.3390/cancers16162779
Available online: https://www.mdpi.com/2072-6694/16/16/2779

6. “Social and Biological Determinants in Lung Cancer Disparity”
by Briana A. Brock, Hina Mir, Eric L. Flenaugh, Gabriela Oprea-Ilies, Rajesh Singh and Shailesh Singh
Cancers 2024, 16(3), 612; https://doi.org/10.3390/cancers16030612
Available online: https://www.mdpi.com/2072-6694/16/3/612

7. “Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments”
by Eleni Kokkotou, Maximilian Anagnostakis, Georgios Evangelou, Nikolaos K. Syrigos and Ioannis Gkiozos
Cancers 2024, 16(7), 1414; https://doi.org/10.3390/cancers16071414
Available online: https://www.mdpi.com/2072-6694/16/7/1414

8. “Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC”
by Oraianthi Fiste, Ioannis Gkiozos, Andriani Charpidou and Nikolaos K. Syrigos
Cancers 2024, 16(4), 831; https://doi.org/10.3390/cancers16040831
Available online:  https://www.mdpi.com/2072-6694/16/4/831

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.